Barcelona, Spain

Juan Gabriel Solsona Rocabert

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Juan Gabriel Solsona Rocabert. Retrieved from https://idiyas.com/inventor/juan-gabriel-solsona-rocabert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Certainly! Here is the article about inventor Juan Gabriel Solsona Rocabert:

Title: Innovator Spotlight - Juan Gabriel Solsona Rocabert

Introduction:

Juan Gabriel Solsona Rocabert, a talented inventor based in Barcelona, Spain, has made significant contributions to the field of pharmaceuticals with his groundbreaking patent on processes for making modulators of the cystic fibrosis transmembrane conductance regulator (CFTR).

Latest Patents:

Juan Gabriel Solsona Rocabert holds one patent for his innovative processes for synthesizing compounds to be used as CFTR modulators, demonstrating his expertise in developing novel pharmaceutical solutions.

Career Highlights:

Currently employed at Vertex Pharmaceuticals, Inc., a renowned pharmaceutical company, Juan Gabriel Solsona Rocabert has showcased his dedication to advancing the treatment of cystic fibrosis through his research and inventions.

Collaborations:

Collaborating with esteemed colleagues such as Berenice Lemercier Lewandowski and Robert Lewis, Juan Gabriel Solsona Rocabert has been able to combine his expertise with the knowledge and skills of other professionals in the field, resulting in successful outcomes and impactful innovations.

Conclusion:

In conclusion, Juan Gabriel Solsona Rocabert stands out as a visionary inventor in the pharmaceutical industry, with his patent on CFTR modulators paving the way for enhanced treatments for individuals with cystic fibrosis. His collaboration with talented individuals and his contribution to Vertex Pharmaceuticals, Inc. reflect his passion for innovation and commitment to making a positive impact on healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…